These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 23997009
1. The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia. Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ, Dawood T, Masuo K, Sari CI, Dixon JB, Esler MD, Paul E, Schlaich MP, Lambert GW. Obesity (Silver Spring); 2014 Mar; 22(3):652-62. PubMed ID: 23997009 [Abstract] [Full Text] [Related]
3. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. Goldstein DS, Cannon RO, Quyyumi A, Chang P, Duncan M, Brush JE, Eisenhofer G. J Auton Nerv Syst; 1991 Jun 01; 34(1):17-35. PubMed ID: 1940014 [Abstract] [Full Text] [Related]
4. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. Eisenhofer G, Meredith IT, Ferrier C, Cox HS, Lambert G, Jennings GL, Esler MD. J Lab Clin Med; 1991 Apr 01; 117(4):266-73. PubMed ID: 1901341 [Abstract] [Full Text] [Related]
5. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss. Straznicky NE, Grima MT, Sari CI, Lambert EA, Phillips SE, Eikelis N, Kobayashi D, Hering D, Mariani JA, Dixon JB, Nestel PJ, Karapanagiotidis S, Schlaich MP, Lambert GW. Cardiovasc Diabetol; 2015 Aug 22; 14():113. PubMed ID: 26297500 [Abstract] [Full Text] [Related]
6. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Eisenhofer G, Esler MD, Goldstein DS, Kopin IJ. Am J Physiol; 1991 Oct 22; 261(4 Pt 1):E505-15. PubMed ID: 1928342 [Abstract] [Full Text] [Related]
7. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma. Atuk NO, Hanks JB, Weltman J, Bogdonoff DL, Boyd DG, Vance ML. J Clin Endocrinol Metab; 1994 Dec 22; 79(6):1609-14. PubMed ID: 7989464 [Abstract] [Full Text] [Related]
8. New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space. Kvetnansky R, Noskov VB, Blazicek P, Macho L, Grigoriev AI, Goldstein DS, Kopin IJ. Acta Astronaut; 1994 Oct 22; 34():243-54. PubMed ID: 11540743 [Abstract] [Full Text] [Related]
9. Plasma levels of catechols during reflexive changes in sympathetic nerve activity. Garty M, Deka-Starosta A, Chang PC, Eisenhofer G, Zukowska-Grojec Z, Stull R, Kopin IJ, Goldstein DS. Neurochem Res; 1989 Jun 22; 14(6):523-31. PubMed ID: 2503766 [Abstract] [Full Text] [Related]
11. Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs. Eisenhofer G, Smolich JJ, Esler MD. Neurochem Int; 1992 Jul 01; 21(1):37-44. PubMed ID: 1303141 [Abstract] [Full Text] [Related]
12. Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism. Izzo JL, Thompson DA, Horwitz D. Life Sci; 1985 Sep 16; 37(11):1033-8. PubMed ID: 4033349 [Abstract] [Full Text] [Related]
13. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Circulation; 1997 Nov 18; 96(10):3423-9. PubMed ID: 9396437 [Abstract] [Full Text] [Related]
14. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. J Clin Invest; 1988 Jan 18; 81(1):213-20. PubMed ID: 3335637 [Abstract] [Full Text] [Related]
15. Sympathoneural and skeletal muscle contributions to plasma dopa responses in pithed rats. Szemeredi K, Pacak K, Kopin IJ, Goldstein DS. J Auton Nerv Syst; 1991 Sep 18; 35(3):169-74. PubMed ID: 1744376 [Abstract] [Full Text] [Related]
16. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Tack CJ, Smits P, Willemsen JJ, Lenders JW, Thien T, Lutterman JA. Diabetes; 1996 Jan 18; 45(1):15-22. PubMed ID: 8522054 [Abstract] [Full Text] [Related]
17. Comparison of plasma 3,4-dihydroxyphenylethylene glycol (DHPG) and norepinephrine levels as indices of sympathetic activity in man. Howes LG, Hawksby CC, Reid JL. Eur J Clin Invest; 1986 Feb 18; 16(1):18-21. PubMed ID: 3084267 [Abstract] [Full Text] [Related]
18. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW. Diabetes; 2010 Jan 18; 59(1):71-9. PubMed ID: 19833893 [Abstract] [Full Text] [Related]
19. Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H, Socratous F, Hastings J, Lambert EA, Ogihara T, Esler MD. Hypertens Res; 2008 Jun 18; 31(6):1093-100. PubMed ID: 18716356 [Abstract] [Full Text] [Related]
20. Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: method development for a translational research study. Denfeld QE, Habecker BA, Woodward WR. BMC Res Notes; 2018 Apr 19; 11(1):248. PubMed ID: 29673396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]